All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

January 26, 2024 – Company announcement no. 1

Please see attachment.

Contact information

Investor Relations
Disa Tuominen
+45 6038 5826
[email protected]

Press Relations
Sanne Seyer-Hansen
+45 6038 6207
[email protected]

Attachment

• No. 1 All necessary regulatory approvals have been obtained